Abstract
Abstract The performance, cost and patient acceptability of two continuous infusion pumps, the Parker 2004 and the CADD-1, were compared in patients receiving continuous infusions of cytotoxic drugs. Eight patients used each pump for a minimum of four weeks. Questionnaires on both pumps were completed by each patient. All patients preferred the Parker pump in almost every respect. Problems encountered with the pumps were recorded over 12 months and an estimate of running costs was made. Fourteen patients used the Parker pump for an average of 20.7 weeks and 11 patients used the CADD-1 pump for an average of 14.1 weeks. Eight patients used both pumps. Using either pump, it was possible to maintain outpatients on infusion therapy with few problems. The Parker pump is more economical to run in continuous operation but is less economical than the CADD-1 pump for giving short infusions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
